Price T Rowe Associates Inc Voyager Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 905,820 shares of VYGR stock, worth $5.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
905,820
Previous 989,549 8.46%
Holding current value
$5.13 Million
Previous $7.83 Million 32.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.77 - $9.27 $483,116 - $776,167
-83,729 Reduced 8.46%
905,820 $5.3 Million
Q2 2024

Aug 14, 2024
SELL
$7.42 - $10.54 $388,667 - $552,095
-52,381 Reduced 5.03%
989,549 $7.83 Million
Q1 2024

May 15, 2024
BUY
$7.15 - $10.84 $265,579 - $402,640
37,144 Added 3.7%
1,041,930 $9.7 Million
Q4 2023

Feb 14, 2024
SELL
$6.28 - $8.81 $1.06 Million - $1.49 Million
-169,301 Reduced 14.42%
1,004,786 $8.48 Million
Q3 2023

Nov 14, 2023
SELL
$7.55 - $11.25 $421,999 - $628,807
-55,894 Reduced 4.54%
1,174,087 $9.1 Million
Q2 2023

Aug 14, 2023
BUY
$6.94 - $13.99 $2.28 Million - $4.6 Million
328,516 Added 36.44%
1,229,981 $14.1 Million
Q1 2023

May 15, 2023
BUY
$6.0 - $10.78 $624,864 - $1.12 Million
104,144 Added 13.06%
901,465 $6.95 Million
Q4 2022

Feb 14, 2023
SELL
$4.94 - $6.61 $229,166 - $306,637
-46,390 Reduced 5.5%
797,321 $4.86 Million
Q3 2022

Nov 14, 2022
BUY
$5.57 - $7.47 $87,788 - $117,734
15,761 Added 1.9%
843,711 $5 Million
Q2 2022

Aug 15, 2022
BUY
$4.82 - $10.09 $3.77 Million - $7.9 Million
782,850 Added 1735.81%
827,950 $4.89 Million
Q1 2022

May 16, 2022
SELL
$2.75 - $9.44 $125,950 - $432,352
-45,800 Reduced 50.39%
45,100 $344,000
Q4 2021

Feb 14, 2022
BUY
$2.47 - $5.55 $3,705 - $8,325
1,500 Added 1.68%
90,900 $246,000
Q3 2021

Nov 15, 2021
BUY
$2.63 - $4.12 $68,117 - $106,708
25,900 Added 40.79%
89,400 $235,000
Q2 2021

Aug 16, 2021
SELL
$3.94 - $5.44 $7,399 - $10,216
-1,878 Reduced 2.87%
63,500 $262,000
Q1 2021

May 17, 2021
BUY
$4.61 - $9.04 $301,392 - $591,017
65,378 New
65,378 $308,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $219M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email